Pα+: MEP Action Group Meets in Brussels to Discuss Regulatory Pathways for Psychedelics
We share our notes from the inaugural meeting of the MEP Action Group for the Medical Use of Psychedelics which took place in Brussels on Monday.
This enhanced article, which includes additional analysis and commentary, is exclusively for Pα+ subscribers. Look out for the red text boxes that contain this additional content.
On Monday, the inaugural meeting of the MEP Action Group for the Medical Use of Psychedelics took place at the European Parliament in Brussels.
The meeting was co-organised by PAREA and PsychedelicsEUROPE, who kindly invited me (Josh Hardman) to present alongside a handful of others: from researchers and industry through to patients and policy advocates...
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks